Literature DB >> 15297222

[Long-term followup of patients with alveolar echinococcosis].

P Charbonnet1, L Bühler, E Sagnak, P Villiger, P Morel, G Mentha.   

Abstract

INTRODUCTION: Alveolar Echinicoccosis is a severe parasitic disease: its natural evolution is comparable to a slowly progressive malignant liver tumour. There is no definitive medical therapy. Surgery remains the only option to assure a cure. This report is our surgical experience for the care of this affection. PATIENTS AND
METHOD: Between 1980 and 2002, 12 patients were operated for an hepatic alveolar echinococcosis. For 11 of them, the affection was primary. Lesions were located in the right liver lobe (n = 9), in the left lobe (n = 1), in both lobes (n = 1) and close to the hilar region (n = 1). Twice there was a diaphragmatic infiltration and once a pleural infiltration. Resections consisted in: segmentectomies in the right lobe (n = 4), right hepatectomy (n = 5, associated once with a partial I and IV segmentectomy), left hepatectomy (n = 1), one liver transplantation (n = 1), one drainage of a parasitic cavity (n = 1). One pleurectomy and a partial diaphragmatic resection were made. All patients were treated postoperatively with benzimidazole chemotherapy.
RESULTS: Three patients presented some complications: segmental necrosis with biloma (n = 1), biliary fistula tract (n = 1), subdiaphragmatic hematoma (n = 1), cholangitis (n = 1). 10 patients are alive (median follow-up of 10 years). Two patients still present some parasitic lesions; the situation remains doubtful for one of them. Two patients died (one of them in the context of a disease progression).
CONCLUSION: Surgical treatment, associated with medical therapy, assured a control of the parasitic lesions or a definitive cure in most cases. When the disease is limited to the liver with no possibility for partial hepatectomy, a transplantation is an option.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297222     DOI: 10.1016/j.anchir.2004.01.017

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  3 in total

1.  Impact of Safe Distance on Long-Term Outcome After Surgical Therapy of Alveolar Echinococcosis.

Authors:  Andreas Hillenbrand; Beate Gruener; Wolfgang Kratzer; Peter Kern; Tilmann Graeter; Thomas F Barth; Klaus Buttenschoen; Doris Henne-Bruns
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

2.  Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.

Authors:  Michael Weingartner; Simon Stücheli; Fadi Jebbawi; Bruno Gottstein; Guido Beldi; Britta Lundström-Stadelmann; Junhua Wang; Alex Odermatt
Journal:  PLoS Negl Trop Dis       Date:  2022-01-14

3.  Analysis of the clinical value of 18F-FDG PET/CT in hepatic alveolar echinococcosis before and after autologous liver transplantation.

Authors:  Yongde Qin; Xiaohong Li; Qizhou Zhang; Bin Xie; Xuewen Ji; Yubin Li; Amina Yiblayan; Hao Wen
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.